Daan Biotherapeutics

Developer of therapeutics for cancer treatment

placeSeoul, Seoul, South Korea calendar_todayFounded 2020 groups4 employees language daanbiotpx.com

Innovation

5 patent families — focus: Chemistry & metallurgy, Human necessities; filing pace accelerating. Cited 28 times.

YearFilings
20231
20241
20253
20262

Investor mix

11 investors on record; lead investors include Solasta Ventures, Company K Partners, Paratus Investment, Atinum Investment.

Investor typeCountShare
Venture capital655%
Private equity327%
Bank & private debt19%
Other / undisclosed19%
Coming soon